BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35404378)

  • 1. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19.
    Ho CY; Salimian M; Hegert J; O'Brien J; Choi SG; Ames H; Morris M; Papadimitriou JC; Mininni J; Niehaus P; Burke A; Canbeldek L; Jacobs J; LaRocque A; Patel K; Rice K; Li L; Johnson R; LeFevre A; Blanchard T; Shaver CM; Moyer A; Drachenberg C
    JAMA Neurol; 2022 Jun; 79(6):544-553. PubMed ID: 35404378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study.
    Qiu C; Cui C; Hautefort C; Haehner A; Zhao J; Yao Q; Zeng H; Nisenbaum EJ; Liu L; Zhao Y; Zhang D; Levine CG; Cejas I; Dai Q; Zeng M; Herman P; Jourdaine C; de With K; Draf J; Chen B; Jayaweera DT; Denneny JC; Casiano R; Yu H; Eshraghi AA; Hummel T; Liu X; Shu Y; Lu H
    Otolaryngol Head Neck Surg; 2020 Oct; 163(4):714-721. PubMed ID: 32539586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Khan M; Yoo SJ; Clijsters M; Backaert W; Vanstapel A; Speleman K; Lietaer C; Choi S; Hether TD; Marcelis L; Nam A; Pan L; Reeves JW; Van Bulck P; Zhou H; Bourgeois M; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Lorent N; Neyrinck A; Peetermans M; Thal DR; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
    Cell; 2021 Nov; 184(24):5932-5949.e15. PubMed ID: 34798069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of COVID-19-associated olfactory dysfunction.
    Chang K; Zaikos T; Kilner-Pontone N; Ho CY
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12960. PubMed ID: 38419211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19.
    Haehner A; Draf J; Dräger S; de With K; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2020; 82(4):175-180. PubMed ID: 32526759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.
    Mendes Paranhos AC; Nazareth Dias ÁR; Machado da Silva LC; Vieira Hennemann Koury G; de Jesus Sousa E; Cerasi AJ; Souza GS; Simões Quaresma JA; Magno Falcão LF
    JAMA Netw Open; 2022 Sep; 5(9):e2230637. PubMed ID: 36074464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Patient-Reported and Clinically Tested Olfactory Dysfunction in a Population Screened for COVID-19.
    Villerabel C; Makinson A; Jaussent A; Picot MC; Nègre-Pagès L; Rouvière JA; Favier V; Crampette L; Morquin D; Reynes J; Le Moing V; Tuaillon E; Venail F
    JAMA Otolaryngol Head Neck Surg; 2021 Mar; 147(3):271-279. PubMed ID: 33410887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primer on viral-associated olfactory loss in the era of COVID-19.
    Soler ZM; Patel ZM; Turner JH; Holbrook EH
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):814-820. PubMed ID: 32271490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle olfactory dysfunction after SARS-CoV-2 virus infection in children.
    Concheiro-Guisan A; Fiel-Ozores A; Novoa-Carballal R; González-Duran ML; Portugués de la Red M; Martínez-Reglero C; Fernández-Pinilla I; González-Guijarro I
    Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110539. PubMed ID: 33307419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.
    Aschman T; Schneider J; Greuel S; Meinhardt J; Streit S; Goebel HH; Büttnerova I; Elezkurtaj S; Scheibe F; Radke J; Meisel C; Drosten C; Radbruch H; Heppner FL; Corman VM; Stenzel W
    JAMA Neurol; 2021 Aug; 78(8):948-960. PubMed ID: 34115106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smell dysfunction: a biomarker for COVID-19.
    Moein ST; Hashemian SM; Mansourafshar B; Khorram-Tousi A; Tabarsi P; Doty RL
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):944-950. PubMed ID: 32301284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory function trends in COVID-19 patients: a prospective cohort study.
    Akbari M; Jalali MM; Akbarpour M; Alavi Foumani A; Sharifnia S
    Acta Otolaryngol; 2022 Jun; 142(6):515-519. PubMed ID: 35723679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.
    Hopkins C; Lechien JR; Saussez S
    Med Hypotheses; 2021 Jan; 146():110406. PubMed ID: 33246692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-viral effects of COVID-19 in the olfactory system and their implications.
    Xydakis MS; Albers MW; Holbrook EH; Lyon DM; Shih RY; Frasnelli JA; Pagenstecher A; Kupke A; Enquist LW; Perlman S
    Lancet Neurol; 2021 Sep; 20(9):753-761. PubMed ID: 34339626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.
    Cho RHW; To ZWH; Yeung ZWC; Tso EYK; Fung KSC; Chau SKY; Leung EYL; Hui TSC; Tsang SWC; Kung KN; Chow EYD; Abdullah V; van Hasselt A; Tong MCF; Ku PKM
    Laryngoscope; 2020 Nov; 130(11):2680-2685. PubMed ID: 32794209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.